arrow
Home
FDA “stands firm” in...

FDA “stands firm” in monitoring CBD marketplace with recent warning letter

Protecting and promoting public health remains a top priority, says FDA Commissioner

25 Jul 2019
-
Aa
+
Click Here
trans